source
- Roche reports narrow failure of breast cancer pill in Phase 3 trial at ASCORoche updated investors and the oncology community that its experimental breast cancer oral therapy did not meet its primary endpoint in a pivotal Phase 3 study. The data, presented at the America…
- Allen Institute launches multi-hundred-million-dollar effort to turn brain atlas data into neurodegenerative drug candidatesThe Allen Institute, a Seattle nonprofit known for basic brain research, announced a major new effort to move its brain‑atlas knowledge toward drug development. The program will invest several hun…